Adenovirus infection of primary malignant lymphoid cells

Leukemia and Lymphoma

Volumn 43, Issue 1, 2002, Pages 37-49

  Strair, Roger K ^a   Sheay, Wendy ^a   Goodell, Lauri ^a   White, Eileen ^b   Rabson, Arnold B ^b   Medina, Daniel J ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

Adenovirus infection; Cytotoxicity; Leukemia; Malignant lymphoid cells

Indexed keywords

GENE PRODUCT; REGULATOR PROTEIN; VIRUS PROTEIN;

ADENOVIRUS; APOPTOSIS; ARTICLE; CANCER CELL; CARCINOGENESIS; CELL CYCLE; CELL DEATH; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; CYTOTOXICITY; HOST CELL; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LYMPHOID CELL LINE; LYMPHOMA CELL LINE; MANTLE CELL LYMPHOMA; MULTIPLE MYELOMA; MYELOMA CELL; PRIORITY JOURNAL; TRANSCRIPTION REGULATION; VIRUS ATTENUATION; VIRUS INFECTION; VIRUS MUTANT; CELL CULTURE; GENETICS; LEUKEMIA; LYMPHOMA; PATHOGENICITY; PATHOLOGY; REVIEW; VIROLOGY;

ADENOVIRIDAE; ADENOVIRIDAE INFECTIONS; CELL DEATH; HUMANS; LEUKEMIA; LYMPHOMA; TUMOR CELLS, CULTURED;

EID: 0036119580     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190210187     Document Type: Article

References (93)

1. "Wild-Type p53 mediates apoptosis by E1A, which is inhibited by E1B"
2. "Control of apoptosis by human adenovirus genes"
3. "Regulation of apoptosis by viral gene products"
4. "Regulation of p53-dependent apoptosis by E1A and E1B"
5. "Anticancer drug targets: Cell cycle and checkpoint control"
6. "A matter of life and cell death"
7. "Mechanisms of apoptosis by c-myc"
8. "Role of the retinoblastoma protein family, pRb, p107, and p130 in the negative control of cell growth"
9. "The complexity of p53 modulation: Emerging patterns from divergent signals"
10. "An adenovirus mutant that replicates selectively in p53-deficient human tumor cells"
11. "Selective replication and oncolysis in p53 mutant tumors with ONYX-015, an E1B-55-kD gene-deleted adenovirus, in patients with advanced head and neck cancer: A phase II clinical trial"
12. "Inactivation of multiple tumor suppressor genes involved in negative regulation of the cell cycle, MTS1/p16INK4A/CDKN2, MTS2/p15INK4B, p53, and Rb genes in primary lymphoid malignancies"
13. "The search for genetic clues in chronic lymphocytic leukemia"
14. "Aberrations of p53 pathway components p53, MDM2 and CDKN2A appear independent in diffuse large cell lymphoma"
15. "Mutations of the p53 gene as a prognostic factor in aggressive B-cell lymphoma"
16. "Regulated genomic instability and neoplasia in the lymphoid lineage"
17. "Frequent somatic hypermutation of the 5′ non-coding region of the bcl 6 gene in B-cell lymphomas"
18. "The biology of high grade non-Hodgkin's lymphomas"
19. "Biallelic mutations in the ATM gene in T-prolymphocytic leukemia"
20. "Inactivation of ATM gene in B-cell chronic lymphocytic leukemia"
21. "Chromosomal abnormalities and molecular genetics of non-Hodgkin's lymphoma"
22. "REL protooncogene is frequently amplified in extranodal diffuse large cell lymphoma"
23. "Molecular pathophysiology of indolent lymphoma"
24. "Apoptosis signaling in lymphocytes"
25. "Self-reacting B-lymphocytes overexpressing Bcl-XL escape negative selection and are tolerized by clonal anergy and receptor editing"
26. "Germinal center cells express bcl-2 after activation by signals which prevent their entry into apoptosis"
27. "Antigen receptor induced apoptosis of human germinal center B-cells is targeted to a centrocytic subset"
28. "Mantle-cell lymphoma"
29. "Cyclin D1 analysis in the diagnosis of mantle cell lymphoma"
30. "Cyclin D1 overexpression combined with N-nitrosomethylbenzamine increases dysplasia and cellular proliferation in murine esophageal squamous epithelium"
31. "Function of a human cyclin as an oncogene"
32. "The regulation of E2F by pRb-family members"
33. "Immunohistochemical detection of E2F-1 in non-Hodgkin's lymphomas: A survey of 124 cases"
34. "Expression of the retinoblastoma gene in low-grade B-cell lymphoma: Relationship to cyclin D1"
35. "Expression of retinoblastoma gene product in mantle cell lymphoma. Correlation with cyclin D1 mRNA levels and proliferative activity"
36. "Physical interactions of the retinoblastoma protein with human D cyclins"
37. "Cyclin D1 associates with the TBP-associated factor TAFII250 to regulate Sp1-mediated transcription"
38. "CDK-independent activities of D-type cyclins"
39. "Regulation of the CD13 aminopeptidase N gene by DMP1 a transcription factor antagonized by D-type cyclins"
40. "Interaction of D-type cyclins with a novel myb-like transcription factor DMP1"
41. "Activation of the cyclin D1 gene by E1A-associated p300 through AP-1 inhibits cellular apoptosis"
42. "Induction of ARF tumor suppressor gene expression and cell cycle arrest by transcription factor DMP1"
43. "Gene expression and cell cycle arrest mediated by transcription factor DMP1 is antagonized by D-type cyclins through a cyclin dependent kinase-independent mechanism"
44. "Functional and physical interactions of the ARF tumor suppressor with p53 and mdm2"
45. "Functional domains in cyclin D1: pRb kinase activity is not essential for transformation"
46. "Stabilization of the p53 tumor suppressor gene is induced by Adenovirus E1A and accompanies apoptosis"
47. "Adenovirus E1A proteins induce apoptosis by both p53-dependent and p53-independent mechanisms"
48. "p300 Binding by E1A cosegregates with p53 induction but is dispensable for apoptosis"
49. "Selective induction of p53 and chemosensitivity in RB-deficient cells by E1A mutants unable to bind the RB-related proteins"
50. "Accumulation of p53 induced by the Adenovirus E1A protein requires regions involved in the induction of DNA synthesis"
51. "E1A signalling to p53 involves the p19ARF tumor suppressor"
52. "Suppression of the p300-Dependent mdm2 negative-feedback loop induces the p53 apoptotic function"
53. "Adenovirus E1B 19-kilodalton protein overcomes the cytotoxicity of E1A proteins"
54. "Deletion of the gene encoding the adenovirus 5 early region 1B 21,000-molecular weight polypeptide leads to degradation of viral and host cell DNA"
55. "Mutations in the gene encoding the adenovirus early region 1B 19,000 molecular weight tumor antigen cause degradation of chromosomal DNA"
56. "19-kDa tumor antigen coded by early region E1B of adenovirus 2 is required for efficient synthesis and for protection of viral DNA"
57. "The adenovirus E1A proteins induce apoptosis which is inhibited by the E1B 19-kDa and Bcl-2 proteins"
58. "P300/MDM2 complexes participate in MDM2 mediated p53 degradation"
59. "Adenovirus E4 34K and E4 11K inhibit double strand break repair and are physically associated with the cellular DNA-dependent protein kinase"
60. "Adenovirus type 5 E4orf3 protein relieves p53 inhibition by E1B-55-kilodalton protein"
61. "Analysis of synthesis, stability, phosphorylation and interacting polypeptides of the 34-kilodalton product of open reading frame 6 of the early region 4 protein of human adenovirus 5"
62. "The large E1B protein together with E4orf6 protein target p53 for active degradation in adenovirus infected cells"
63. "Transforming potential of the adenovirus type 5 E4orf3 protein"
64. "Nuclear export of E1B-55 kda and E4-34 kDa adenoviral oncoproteins mediated by a rev-like signal"
65. "The early region 4 orf protein of human adenovirus type 5 induces p53-independent cell death by apoptosis"
66. "Adenovirus type 5 E4 open reading frame 4 induces apoptosis in transformed cells"
67. "E4orf4, a novel adenovirus death factor that induces p53-independent apoptosis by a pathway that is not inhibited by zVAD-fmk"
68. "Induction of apoptosis by adenovirus E4orf4 is specific to transformed cells and requires interaction with protein phosphatase 2A"
69. "Blockage by adenovirus E4orf6 of transcriptional activation by the p53 tumor suppressor"
70. "The early region 1B 55 kilodalton oncoprotein of adenovirus relieves growth restriction imposed on viral replication by the cell cycle"
71. "The adenovirus E4orf6 protein contributes to malignant transformation by antagonizing E1A-induced accumulation of the tumor suppressor protein p53"
72. "Adenovirus E1B 19-kDa and Bcl-2 proteins interact with a common set of cellular proteins"
73. "Functional complementation of the adenovirus E1B 19-kilodalton protein with bcl-2 in the inhibition of apoptosis in infected cells"
74. "BIK, a novel death inducing protein shares a distinct sequence motif with bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins"
75. "Cloning of a bcl-2 homologue by interaction with adenovirus E1B-19K"
76. "The E1B 19K protein blocks apoptosis by interacting with and inhibiting the p53-inducible and death-promoting Bax protein"
77. "Induction of apoptosis by human Nbk/Bik, a BH3 containing protein that interacts with E1B-19K"
78. "Adenovirus E1B-58-kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54-kd cellular protein in transformed cells"
79. "Adenovirus E1B oncoprotein tethers a transcriptional repression domain to p53"
80. "Regulation of p53-dependent apoptosis, transcriptional repression and cell transformation by phosphorylation of the 55 kilodalton E1B protein of adenovirus 5"
81. "A revised European-American classification of hematopoietic neoplasms: A proposal from the international lymphoma study group"
82. "The apoptosis inhibitor gene AP12 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas"
83. "An Adenovirus Type 5 early gene function regulates expression of other viral genes"
84. "Introduction, stable integration, and controlled expression of a chimeric adenovirus gene whose product is toxic to the recipient human cell"
85. "CD47 ligation induces caspase-independent cell death in chronic lymphocytic leukemia"
86. "Ceramide-induced killing of normal and malignant human lymphocytes is by a non-apoptotic mechanism"
87. "Bcl-2 family proteins"
88. "Biochemical and genetic control of apoptosis relevance to normal hematopoiesis and hematologic malignancies"
89. "Adenovirus-mediated cytotoxicity of chronic lymphocytic leukemia cells"
90. "Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML"
91. "Gene marking to trace origin of relapse after autologous bone marrow transplantation"
92. "Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma"
93. "Circulating cells carrying t(14:18) in long remission from follicular lymphoma"